News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
284,817 Results
Type
Article (16001)
Company Profile (283)
Press Release (268533)
Section
Business (82738)
Career Advice (178)
Deals (13777)
Drug Delivery (36)
Drug Development (52794)
Employer Resources (33)
FDA (6815)
Job Trends (5504)
News (152166)
Policy (11026)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (993)
Accelerated approval (3)
Adcomms (14)
Allergies (52)
Alliances (22488)
ALS (62)
Alzheimer's disease (844)
Antibody-drug conjugate (ADC) (90)
Approvals (6831)
Artificial intelligence (117)
Autoimmune disease (14)
Automation (5)
Bankruptcy (109)
Best Places to Work (4904)
BIOSECURE Act (5)
Biosimilars (46)
Biotechnology (232)
Bladder cancer (45)
Brain cancer (20)
Breast cancer (145)
Cancer (1360)
Cardiovascular disease (112)
Career advice (154)
Career pathing (3)
CAR-T (117)
Cell therapy (326)
Cervical cancer (8)
Clinical research (42939)
Collaboration (516)
Compensation (245)
Complete response letters (13)
COVID-19 (1048)
CRISPR (38)
C-suite (149)
Cystic fibrosis (76)
Data (1440)
Decentralized trials (1)
Denatured (11)
Depression (29)
Diabetes (127)
Diagnostics (1372)
Digital health (3)
Diversity (3)
Diversity, equity & inclusion (11)
Drug discovery (82)
Drug pricing (28)
Drug shortages (4)
Duchenne muscular dystrophy (84)
Earnings (31016)
Editorial (18)
Employer branding (4)
Employer resources (32)
Events (50188)
Executive appointments (418)
FDA (7499)
Featured Employer (31)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (480)
Gene editing (91)
Generative AI (10)
Gene therapy (243)
GLP-1 (374)
Government (1179)
Grass and pollen (2)
Guidances (21)
Healthcare (7322)
Huntington's disease (21)
IgA nephropathy (22)
Immunology and inflammation (81)
Indications (18)
Infectious disease (1110)
Inflammatory bowel disease (112)
Inflation Reduction Act (8)
Influenza (18)
Intellectual property (60)
Interviews (26)
IPO (7449)
IRA (11)
Job creations (897)
Job search strategy (141)
Kidney cancer (6)
Labor market (4)
Layoffs (205)
Leadership (4)
Legal (1556)
Liver cancer (33)
Lung cancer (191)
Lymphoma (92)
Machine learning (2)
Management (8)
Manufacturing (119)
MASH (50)
Medical device (3463)
Medtech (3464)
Mergers & acquisitions (6629)
Metabolic disorders (377)
Multiple sclerosis (51)
NASH (13)
Neurodegenerative disease (65)
Neuropsychiatric disorders (23)
Neuroscience (1232)
NextGen: Class of 2025 (2200)
Non-profit (977)
Northern California (1644)
Now hiring (22)
Obesity (194)
Opinion (103)
Ovarian cancer (61)
Pain (47)
Pancreatic cancer (51)
Parkinson's disease (115)
Partnered (8)
Patents (115)
Patient recruitment (69)
Peanut (36)
People (26368)
Pharmaceutical (49)
Pharmacy benefit managers (5)
Phase I (14906)
Phase II (19765)
Phase III (12907)
Pipeline (778)
Podcasts (47)
Policy (39)
Postmarket research (1004)
Preclinical (6270)
Press Release (30)
Prostate cancer (59)
Psychedelics (35)
Radiopharmaceuticals (213)
Rare diseases (288)
Real estate (1489)
Recruiting (12)
Regulatory (9371)
Reports (16)
Research institute (1058)
Resumes & cover letters (20)
Rett syndrome (4)
RNA editing (4)
RSV (10)
Schizophrenia (57)
Series A (93)
Series B (60)
Service/supplier (1)
Sickle cell disease (44)
Southern California (1430)
Special edition (11)
Spinal muscular atrophy (119)
Sponsored (11)
Startups (2029)
State (1)
Stomach cancer (4)
Supply chain (21)
Tariffs (3)
The Weekly (35)
United States (12789)
Vaccines (216)
Venture capitalists (28)
Webinars (7)
Weight loss (110)
Women's health (15)
Worklife (2)
Date
Today (66)
Last 7 days (423)
Last 30 days (1568)
Last 365 days (20584)
2025 (5185)
2024 (21315)
2023 (23228)
2022 (28221)
2021 (29205)
2020 (24633)
2019 (17507)
2018 (12738)
2017 (14770)
2016 (12800)
2015 (15395)
2014 (11172)
2013 (8141)
2012 (8226)
2011 (8399)
2010 (8076)
Location
Africa (160)
Alabama (40)
Alaska (2)
Arizona (59)
Arkansas (6)
Asia (18107)
Australia (3085)
California (3695)
Canada (1075)
China (329)
Colorado (144)
Connecticut (150)
Delaware (92)
Europe (39316)
Florida (479)
Georgia (113)
Idaho (20)
Illinois (236)
India (9)
Indiana (103)
Iowa (1)
Japan (75)
Kansas (61)
Kentucky (6)
Louisiana (3)
Maine (11)
Maryland (469)
Massachusetts (2899)
Michigan (71)
Minnesota (140)
Mississippi (1)
Missouri (24)
Montana (16)
Nebraska (4)
Nevada (15)
New Hampshire (14)
New Jersey (933)
New Mexico (12)
New York (998)
North Carolina (545)
North Dakota (4)
Northern California (1644)
Ohio (110)
Oklahoma (9)
Oregon (21)
Pennsylvania (702)
Puerto Rico (3)
Rhode Island (16)
South America (235)
South Carolina (4)
Southern California (1430)
Tennessee (28)
Texas (438)
Utah (50)
Virginia (75)
Washington D.C. (29)
Washington State (328)
Wisconsin (13)
284,817 Results for "bone therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Obesity
Amgen Suffers Surprise Blow as New Bone Density Safety Concerns for MariTide Surface
Cantor Fitzgerald analyst Olivia Brayer found supplementary bone mineral density data for Amgen’s obesity candidate MariTide that could point to a potentially greater fracture risk than previously revealed, but some other analysts view the findings as a nonissue.
November 13, 2024
·
2 min read
·
Tristan Manalac
Press Releases
City of Hope Opens Trial to Test Bone Medication for Early Type 1 Diabetes Treatment
March 20, 2025
·
4 min read
Press Releases
Kelun-Biotech’s Radionuclide-Drug Conjugate (RDC) SKB107 Receives NMPA Approval For The Treatment of Bone Metastases in Solid Tumors
March 26, 2025
·
3 min read
Genetown
First Two Patients Treated in Pilot Clinical Study with Bone Biologics’ NB1 Bone Graft Device in Spine Fusion
Bone Biologics Corporation announces that the first two patients have been treated in the multicenter, prospective, randomized pilot clinical study of the Company’s NB1 bone graft device.
June 20, 2024
·
5 min read
Press Releases
YolTech Therapeutics to Initiate a Clinical Trial for YOLT-204, a First-in-Class Bone Marrow-Targeted In Vivo Gene Editing Therapy for β-Thalassemia
January 20, 2025
·
3 min read
Press Releases
Orthofix Receives 510(k) Clearance and CE Mark for TrueLok Elevate Transverse Bone Transport System
March 19, 2025
·
5 min read
Press Releases
Novadip reports promising interim results from its first-in-human proof-of-concept trial with NVDX3, a new game changer in the bone field
At six months post-grafting surgery with NVDX3, x-rays demonstrate that 90% of patients have reached, or are steadily progressing towards, complete bone healing Derived from Novadip’s 3M3 stem cell platform, NVDX3, a unique ‘off-the-shelf allogeneic matrix product to cure common but challenging orthopedic conditions, has potential to replace existing allogeneic bone substitutes to heal fractures
October 18, 2024
·
1 min read
Press Releases
Nanox to Present New Data Featuring AI Bone Solution at Four Medical Conferences through June 2025 across Europe
March 27, 2025
·
7 min read
Drug Development
BioMarin to Present Data Highlighting Significant Impact of VOXZOGO® (vosoritide) in Bone Health and Health-Related Quality of Life in Achondroplasia at 2024 International Conference on Children’s Bone Health
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced the presentation of new data from an investigator-led analysis of the Phase 2 111-205 study, which demonstrate that children with achondroplasia treated with VOXZOGO® experienced increases in bone length while maintaining bone strength.
June 17, 2024
·
13 min read
Press Releases
SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2024 and Issues 2025 Guidance
February 25, 2025
·
10 min read
1 of 28,482
Next